Sun Pharmaceutical Industries Limited. Sun Pharma announces US FDA acceptance of supplemental Biologics License Application ...
IRA revisions now exempt multi-indication orphan drugs from price negotiations, improving lifecycle economics and encouraging ...
FDA approves leucovorin for cerebral folate deficiency, signaling how literature-based evidence can support rare disease approvals without clinical trials.
Welcome back to the PharmTech Weekly Roundup! I’m Susan Haigney, lead editor of PharmTech. This week, the industry ...
For INTERPHEX NYC, taking place April 21-23, groninger will debut a formalized service structure and put a high-throughput ...
The two companies have entered into a licensing agreement to commercialize biosimilars in Latin America.
FDA replaces seven fragmented adverse event databases with AEMS, enabling real-time safety signal access for pharmaceutical manufacturers and researchers. On March 11, the FDA launched a unified ...
Japan's largest pharma event returns May 2026 with 320 sessions spanning manufacturing, quality, CMC, and digital transformation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results